Liu X, Guo L, Xie FY, Hu WH, et al. Necrosis in a Biomarker-driven, Phase 2 Trial of Adjuvant Apatinib in Patients of
Nasopharyngeal Carcinoma with Residual Epstein-Barr Virus DNA after Radiotherapy. Int J Radiat Oncol Biol Phys 2022 May 9. pii: S0360-3016(22)00410.
PMID: 35550406